Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion
MarketBeat
Edap Tms (NASDAQ:EDAP) used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play robotic focal therapy company,” with management emphasizing the company’s Focal One robotic high-intensity focused ultrasound, or HIFU, platform for prostate cancer and futur
NASDAQ:EDAP